Cited by 690Lipid metabolism and disordersLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Overproduction of large VLDL particles is driven by increased liver fat content in man

Open access

Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., Borén, J.·2006·Diabetologia

DOI 10.1007/s00125-005-0125-z

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis We determined whether hepatic fat content and plasma adiponectin concentration regulate VLDL(1) production.Methods A multicompartment model was used to simultaneously determine the kinetic parameters of triglycerides (TGs) and apolipoprotein B (ApoB) in VLDL(1) and VLDL(2) after a bolus of [(2)H(3)]leucine and [(2)H(5)]glycerol in ten men with type 2 diabetes and in 18 non-diabetic men. Liver fat content was determined by proton spectroscopy and intra-abdominal fat content by MRI.Results Univariate regression analysis showed that liver fat content, intra-abdominal fat volume, plasma glucose, insulin and HOMA-IR (homeostasis model assessment of insulin resistance) correlated with VLDL(1) TG and ApoB production. However, only liver fat and plasma glucose were significant in multiple regression models, emphasising the critical role of substrate fluxes and lipid availability in the liver as the driving force for overproduction of VLDL(1) in subjects with type 2 diabetes. Despite negative correlations with fasting TG levels, liver fat content, and VLDL(1) TG and ApoB pool sizes, adiponectin was not linked to VLDL(1) TG or ApoB production and thus was not a predictor of VLDL(1) production. However, adiponectin correlated negatively with the removal rates of VLDL(1) TG and ApoB.Conclusions/interpretation We propose that the metabolic effect of insulin resistance, partly mediated by depressed plasma adiponectin levels, increases fatty acid flux from adipose tissue to the liver and induces the accumulation of fat in the liver. Elevated plasma glucose can further increase hepatic fat content through multiple pathways, resulting in overproduction of VLDL(1) particles and leading to the characteristic dyslipidaemia associated with type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-005-0125-z

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Banting Lecture 2001
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370

Show all 53 references

Research works printed but not linked: 2

World Health Organization (1999) Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance. World Health Organization, Geneva
Lindgren F, Jensen L (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed.) Blood lipids and lipoproteins: quantification, composition and metabolism. Wiley, Livermore, CA, pp 182–217

Sorted by citations

Items 301–400 of 689

The challenge of managing dyslipidemia in patients with nonalcoholic fatty liver disease
Bril, F., Lomonaco, R., & Cusi, K. J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.47 · Cited by 32
Clinical significance of small dense low‐density lipoprotein cholesterol measurement in type 2 diabetes
Hirano, T. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14398 · Cited by 36
WHO (WORLD HEALTH ORGANIZATION)
(2007) · Routledge eBooks · doi:10.4324/9780203098837-59 · Cited by 30
Ectopic fat in youth: The contribution of hepatic and pancreatic fat to metabolic disturbances
Cohen, M., Syme, C. A., Deforest, M., Wells, G. D., Detzler, G., Cheng, H. M., McCrindle, B. W., Hanley, A. J., & Hamilton, J. K. (2013) · Obesity · doi:10.1002/oby.20674 · Cited by 31
FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study
Cabré, A., Babió, N., Lázaro, I., Bulló, M., García‐Arellano, A., Masana, L., & Salas‐Salvadó, J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.003 · Cited by 31
Congenital Lipodystrophies and Dyslipidemias
Prieur, X., May, C. L., Magré, J., & Cariou, B. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0437-x · Cited by 33
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
Taskinen, M., Björnson, E., Andersson, L. K., Kahri, J., Porthan, K., Matikainen, N., Söderlund, S., Pietiläinen, K. H., Hakkarainen, A., Lundbom, N. M. I., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.12.003 · Cited by 31
Self-citation
Prevalencia de hipertrigliceridemia en adultos y factores cardiometabólicos asociados. Estudio SIMETAP-HTG
Ruiz‐García, A., Arranz-Martínez, E., López-Uriarte, B., Rivera-Teijido, M., Martinez, D., Dávila-Blázquez, G. M., Rosillo-González, A., Delgado, J. A. G.-P., Mariño-Suárez, J. E., Revilla-Pascual, E., et al. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.04.001 · Cited by 34
Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes
de Carvalho, L. S. F., Benseñor, I. M., Nogueira, A. C. C., Duncan, B. B., Schmidt, M. I., Blaha, M. J., Toth, P. P., Jones, S. R., Santos, R. D., Lotufo, P. A., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05322-1 · Cited by 30
Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study
Vergès, B. L., Adiels, M., Borén, J., Barrett, P. H. R., Watts, G. F., Chan, D. C., Duvillard, L., Söderlund, S., Matikainen, N., Kahri, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2365 · Cited by 32
Self-citation
Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids
Brouwers, M. C. G. J., Bilderbeek-Beckers, M. A. L., Georgieva, A. M., Kallen, C., van Greevenbroek, M. M. J., & de Bruin, T. W. (2006) · Clinical Science · doi:10.1042/cs20060190 · Cited by 30
Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review
Taghizadeh, E., Mardani, R., Rostami, D., Taghizadeh, H., Bazireh, H., & Hayat, S. M. G. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28311 · Cited by 29
Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease
Moreno‐Vedia, J., Rosales, R., Ozcariz, E., Llop, D., Lahuerta, M., Benavent, M., Rodríguez‐Calvo, R., Plana, N., Pedragosa, À., Masana, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.775677 · Cited by 29
Liver-derived metabolites as signaling molecules in fatty liver disease
Keles, U., Ow, J. R., Kuentzel, K. B., Zhao, L. N., & Kaldis, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04658-8 · Cited by 32
The Quest for the Optimal Assessment of Global Cardiovascular Risk: Are Traditional Risk Factors and Metabolic Syndrome Partners in Crime?
Arsenault, B. J., Pîbarot, P., & Després, J. (2008) · Cardiology · doi:10.1159/000165919 · Cited by 28
HDL metabolism in context: looking on the bright side
Watts, G. F., Barrett, P. H. R., & Chan, D. C. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328306596d · Cited by 30
Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women
Kunnari, A., Santaniemi, M., Jokela, M., Karjalainen, A. H., Heikkinen, J. E., Ukkola, O. H., & Kesäniemi, Y. A. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.004 · Cited by 29
Prescription of statins in suspected non‐alcoholic fatty liver disease and high cardiovascular risk, a population‐based study
van den Berg, E. H., Wolters, A. A. B., Dullaart, R. P. F., Moshage, H. J., Zurakowski, D., de Meijer, V. E., & Blokzijl, H. (2019) · Liver International · doi:10.1111/liv.14116 · Cited by 28
Liver fat as risk factor of hepatic and cardiometabolic diseases
Demir, M., Bornstein, S. R., Mantzoros, C. S., & Perakakis, N. (2023) · Obesity Reviews · doi:10.1111/obr.13612 · Cited by 31
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study
Lorenzo, C., Hanley, A. J., Rewers, M., & Haffner, S. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2826-4 · Cited by 28
Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease
Nass, K. J., van den Berg, E. H., Gruppen, E. G., & Dullaart, R. P. F. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12988 · Cited by 28
Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk
Piché, M., Vasan, S. K., Hodson, L., & Karpe, F. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000522 · Cited by 30
Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation
Queathem, E. D., Moazzami, Z., Stagg, D. B., Nelson, A. B., Fulghum, K., Hayir, A., Seay, A., Gillingham, J. R., d’Avignon, D. A., Han, X., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads0535 · Cited by 30
Measuring Visceral and Hepatic Fat in Clinical Practice and Clinical Research
Naboush, A., & Hamdy, O. (2013) · Endocrine Practice · doi:10.4158/ep12331.or · Cited by 27
Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
van den Berg, E. H., Corsetti, J. P., Bakker, S. J. L., & Dullaart, R. P. F. (2019) · PLOS ONE · doi:10.1371/journal.pone.0220659 · Cited by 27
Association Between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A First Message Should Pass
Picardi, A., & Gentilucci, U. V. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02196.x · Cited by 27
Inhibition of the central melanocortin system decreases brown adipose tissue activity
Kooijman, S., Boon, M. R., Parlevliet, E. T., Geerling, J. J., van de Pol, V., Romijn, J. A., Havekes, L. M., Meurs, I., & Rensen, P. C. N. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045989 · Cited by 27
An extended fatty liver index to predict non-alcoholic fatty liver disease
Kantartzis, K., Rettig, I., Staiger, H., Machann, J., Schick, F., Scheja, L., Gastaldelli, A., Bugianesi, E., Peter, A., Schulze, M. B., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.11.006 · Cited by 27
Treatment of metabolic syndrome with ankaflavin, a secondary metabolite isolated from the edible fungus Monascus spp.
Hsu, W.-H., & Pan, T. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5716-5 · Cited by 26
Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2
Irshad, Z., Chmel, N. P., Adya, R., & Zammit, V. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m089300 · Cited by 26
Relationship between resolution of non‐alcoholic steatohepatitis and changes in lipoprotein sub‐fractions: a post‐hoc analysis of the PIVENS trial
Corey, K. E., Wilson, L., Altınbaş, A., Yates, K. P., Kleiner, D. E., Chung, R. T., Krauss, R. M., & Chalasani, N. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15216 · Cited by 26
Utility of hypertriglyceridemic waist phenotype for predicting incident type 2 diabetes: The Isfahan Diabetes Prevention Study
Janghorbani, M., & Amini, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12520 · Cited by 21
Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis
Alves‐Bezerra, M., Li, Y., Acuña, M., Ivanova, A., Corey, K. E., Ortlund, E. A., & Cohen, D. E. (2018) · Hepatology · doi:10.1002/hep.30411 · Cited by 26
Simple steatosis is a more relevant source of serum inflammatory markers than omental adipose tissue
Li, Y., Liu, L., Wang, B., Wang, J., & Chen, D. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.08.006 · Cited by 25
Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
Hieronimus, B., Griffen, S. C., Keim, N. L., Bremer, A. A., Berglund, L., Nakajima, K., Havel, P. J., & Stanhope, K. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070913 · Cited by 26
Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study
Ruiz‐García, A., Arranz-Martínez, E., López-Uriarte, B., Rivera-Teijido, M., Martinez, D., Dávila-Blázquez, G. M., Rosillo-González, A., Delgado, J. A. G.-P., Mariño-Suárez, J. E., Revilla-Pascual, E., et al. (2020) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2020.11.002 · Cited by 26
Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
Simões, I. C. M., Janikiewicz, J., Bauer, J., Karkucińska‐Więckowska, A., Kalinowski, P., Dobrzyń, A., Wolski, A., Pronicki, M., Zieniewicz, K., Dobrzyń, P., et al. (2019) · Nutrients · doi:10.3390/nu11122871 · Cited by 27
Houttuynia cordata Attenuates Lipid Accumulation via Activation of AMP-Activated Protein Kinase Signaling Pathway in HepG2 Cells
Kang, H. W., & Koppula, S. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500426 · Cited by 25
Insulin Resistance in Type 2 Diabetes
Yki‐Järvinen, H. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch11 · Cited by 27
Self-citation
Hepatoprotective Effect of Houttuynia cordata Thunb Extract against Carbon Tetrachloride-induced Hepatic Damage in Mice.
Kang, H., & Koppula, S. (2014) · Europe PMC (PubMed Central) · Cited by 24
Circulating Very-Low-Density Lipoprotein Characteristics Resulting from Fatty Liver in an Insulin Resistance Rat Model
Zago, V., Lucero, D., Macri, E. V., Cacciagiú, L. D., Gamba, C., Miksztowicz, V., Berg, G. A., Wikinski, R. L. W., Friedman, S., & Schreier, L. E. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000276596 · Cited by 24
Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: A 3‐month placebo‐controlled clinical trial in patients with type 2 diabetes and healthy controls
Gormsen, L. C., Søndergaard, E., Christensen, N. L., Jakobsen, S., Nielsen, E. N., Munk, O. L., Tolbod, L. P., Jessen, N., & Nielsen, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13244 · Cited by 26
Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art
Vahdat‐Lasemi, F., Mahjoubin‐Tehran, M., Aghaee‐Bakhtiari, S. H., Jalili, A., Jaafari, M. R., & Sahebkar, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.04.007 · Cited by 24
Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats
Abdelmoneim, D., El‐Adl, M., El‐Sayed, G., & Said, E. S. E. S. E. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12597 · Cited by 24
Investigations of a compartmental model for leucine kinetics using non-linear mixed effects models with ordinary and stochastic differential equations
Berglund, M., Sunnåker, M., Adiels, M., Jirstrand, M., & Wennberg, B. (2011) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqr021 · Cited by 23
Self-citation
Protective and therapeutic effects ofCrataegus aroniain non-alcoholic fatty liver disease
Humayed, S. A. (2016) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2016.1205097 · Cited by 23
Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol
van den Berg, E. H., Gruppen, E. G., James, R. W., Bakker, S. J. L., & Dullaart, R. P. F. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p088997 · Cited by 23
Genome metabolome integrated network analysis to uncover connections between genetic variants and complex traits: an application to obesity
Valcárcel, B., Ebbels, T. M. D., Kangas, A. J., Soininen, P., Elliott, P., Ala‐Korpela, M., Järvelin, M., & Iorio, M. D. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0908 · Cited by 22
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
Matikainen, N., Björnson, E., Söderlund, S., Borén, C., Eliasson, B., Pietiläinen, K. H., Bogl, L. H., Hakkarainen, A., Lundbom, N. M. I., Rivellese, A. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145890 · Cited by 22
Self-citation
Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults
Jiang, B., Chen, Y., Zhou, K., Zheng, Y., Chen, Y., Qin, L., Zhu, C., Xia, F., Gu, T., Guo, Y., et al. (2019) · Obesity · doi:10.1002/oby.22432 · Cited by 22
Direct assessment of very-low-density lipoprotein by mass sensitive sensor with molecularly imprinted polymers
Chunta, S., Boonsriwong, W., Wattanasin, P., Naklua, W., & Lieberzeit, P. A. (2020) · Talanta · doi:10.1016/j.talanta.2020.121549 · Cited by 23
Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
Wu, T., Ye, J., Shao, C., Li, F., Lin, Y., Ma, Q., Wang, W., Feng, S., & Zhong, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.691556 · Cited by 22
Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype
Petäjä, E. M., Sevastianova, K., Hakkarainen, A., Orho‐Melander, M., Lundbom, N. M. I., & Yki‐Järvinen, H. (2013) · Obesity · doi:10.1002/oby.20114 · Cited by 22
Self-citation
Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes
Sokup, A., Góralczyk, B., Góralczyk, K., & Rość, D. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01289.x · Cited by 22
Consumption ofPuerariaFlower Extract Reduces Body Mass Indexviaa Decrease in the Visceral Fat Area in Obese Humans
Kamiya, T., Takano, A., Matsuzuka, Y., Kusaba, N., Ikeguchi, M., Takagaki, K., & Kondo, K. N. (2012) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120235 · Cited by 22
Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study
Zhang, Y., He, H., Zeng, Y., Yang, L., Jia, D. T., An, Z., & Jia, W. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01310-x · Cited by 22
Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk
Westcott, F., Dearlove, D., & Hodson, L. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117237 · Cited by 22
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size
van Schalkwijk, D. B., de Graaf, A. A., van Ommen, B., van Bochove, K., Rensen, P. C. N., Havekes, L. M., van de Pas, N. C. A., Hoefsloot, H. C. J., van der Greef, J., & Freidig, A. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800354-jlr200 · Cited by 21
Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol
Hosoyamada, K., Uto, H., Imamura, Y., Hiramine, Y., Toyokura, E., Hidaka, Y., Kuwahara, T., Kusano, K., Saito, K., Oketani, M., et al. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-34 · Cited by 21
Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection
Bridge, S. H., Sheridan, D. A., Felmlee, D. J., Nielsen, S. U., Thomas, H. C., Taylor-Robinson, S. D., Neely, R. D. G., Toms, G. L., & Bassendine, M. F. (2010) · Gut · doi:10.1136/gut.2010.222133 · Cited by 21
The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go
Smith, K., Davies, K. A. B., Stevenson, E., & West, D. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.587843 · Cited by 23
Effect of pioglitazone on various parameters of insulin resistance including lipoprotein subclass according to particle size by a gel-permeation high-performance liquid chromatography in newly diagnosed patients with type 2 diabetes
Nakano, K., Hasegawa, G., Fukui, M., Yamasaki, M., Ishihara, K., Takashima, T., Kitagawa, Y., Fujinami, A., Ohta, M., Hara, H., et al. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-006 · Cited by 21
Basal Insulin: Beyond Glycemia
Niswender, K. D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2301 · Cited by 20
Metabolism of Triglyceride-Rich Lipoproteins
Borén, J., & Taskinen, M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_520 · Cited by 22
Self-citation
Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis
Soffientini, U., Caridis, A.-M., Dolan, S., & Graham, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.002 · Cited by 20
Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men
Wong, A. T. Y., Chan, D. C., Ooi, E. M. M., Ng, T. W., Watts, G. F., & Barrett, P. H. R. (2013) · Clinical Science · doi:10.1042/cs20120587 · Cited by 20
Gender Differences in VLDL1and VLDL2Triglyceride Kinetics and Fatty Acid Kinetics in Obese Postmenopausal Women and Obese Men
Šarac, I., Backhouse, K., Shojaee‐Moradie, F., Stolinski, M., Robertson, M. D., Bell, J. D., Thomas, E. L., Hovorka, R., Wright, J., & Umpleby, A. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3248 · Cited by 20
High Sucrose Intake Ameliorates the Accumulation of Hepatic Triacylglycerol Promoted by Restraint Stress in Young Rats
Corona‐Pérez, A., Díaz‐Muñoz, M., Rodríguez, I. S., Cuevas‐Romero, E., Martínez–Gómez, M., Castelán, F., Rodríguez‐Antolín, J., & Nicolás‐Toledo, L. (2015) · Lipids · doi:10.1007/s11745-015-4066-0 · Cited by 20
Involvement of senescence marker protein‐30 in glucose metabolism disorder and non‐alcoholic fatty liver disease
Kondo, Y., & Ishigami, A. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12722 · Cited by 22
The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD
Sasson, A., Kristoferson, E., Batista, R. O., McClung, J. A., Abraham, N. G., & Peterson, S. J. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108679 · Cited by 20
Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes
Dullaart, R. P. F., de Vries, R., Kwakernaak, A. J., Perton, F. G., & Dallinga‐Thie, G. M. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12377 · Cited by 19
Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes
Johansen, R. F., Søndergaard, E., Sørensen, L. P., Jurik, A. G., Christiansen, J. S., & Nielsen, S. (2016) · Diabetologia · doi:10.1007/s00125-015-3856-5 · Cited by 19
The Role of Visceral Adipose Tissue in the Pathogenesis of Non-alcoholic Fatty Liver Disease
Verrijken, A., Francque, S., & Gaal, L. V. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2011.07.02.96 · Cited by 18
Mathematical model of diabetes and lipid metabolism linked to diet, leptin sensitivity, insulin sensitivity and VLDLTG clearance predicts paths to health and type II diabetes
Sweatman, C. Z. W. H. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110037 · Cited by 19
Ketogenesis mitigates metabolic dysfunction–associated steatotic liver disease through mechanisms that extend beyond fat oxidation
Queathem, E. D., Stagg, D. B., Nelson, A. B., Chaves, A., Crown, S. B., Fulghum, K., d’Avignon, D. A., Ryder, J. R., Bolan, P. J., Hayir, A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191021 · Cited by 26
Incidence of type 2 diabetes in familial combined hyperlipidemia
Brouwers, M. C. G. J., Graaf, J. D., Simons, N., Meex, S. J. R., ten Doeschate, S., van Heertum, S., Heidemann, B. E., Luijten, J., de Boer, D., Schaper, N. C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001107 · Cited by 19
Atherogenic lipidomics profile in healthy individuals with low cardiorespiratory fitness: The HUNT3 fitness study
Nodeland, M., Klevjer, M., Sæther, J. C., Giskeødegård, G. F., Bathen, T. F., Wisløff, U., & Bye, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.01.001 · Cited by 19
Increased liver fat associates with severe metabolic perturbations in low birth weight men
Brøns, C., Thuesen, A. C. B., Elingaard-Larsen, L. O., Justesen, L., Jensen, R. T., Henriksen, N. S., Juel, H. B., Størling, J., Ried‐Larsen, M., Sparks, L. M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1221 · Cited by 18
Emerging role of lipophagy in liver disorders
Nazeer, B., Khawar, M. B., Khalid, M. U., Hamid, S. E., Rafiq, M., Abbasi, M. H., Sheikh, N., Ali, A. H., Fatima, H., & Ahmad, S. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04707-1 · Cited by 18
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization
Pennisi, G., Maurotti, S., Ciociola, E., Jamialahmadi, O., Bertolazzi, G., Mirarchi, A., Bergh, P., Scionti, F., Mancina, R. M., Spagnuolo, R., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319789 · Cited by 17
Self-citation
Hepatic VLDL Overproduction: Is Hyperinsulinemia or Insulin Resistance the Culprit?
Gill, J. M. R., & Sattar, N. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0690 · Cited by 18
Bebidas azucaradas, más que un simple refresco
Paulo Silva, O., & Durán‐Agüero, S. (2014) · Revista chilena de nutrición · doi:10.4067/s0717-75182014000100013 · Cited by 24
Difference between Fasting and Nonfasting Triglyceridemia; the Influence of Waist Circumference
Oka, R., Kobayashi, J., Miura, K., Nagasawa, S., Moriuchi, T., Hifumi, S., Miyamoto, S., Kawashiri, M., Nohara, A., Inazu, A., et al. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.406 · Cited by 18
Liver Fat and Insulin Sensitivity Define Metabolite Profiles During a Glucose Tolerance Test in Young Adult Twins
Rämö, J. T., Kaye, S. M., Jukarainen, S., Bogl, L. H., Hakkarainen, A., Lundbom, J., Lundbom, N. M. I., Rissanen, A., Kaprio, J. A., Matikainen, N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3512 · Cited by 20
Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats
Ueno (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000133 · Cited by 18
Influence of Dietary Inositol Supplementation on Growth, Liver Histology, Lipid Metabolism, and Related Genes Expression on Juvenile Hybrid Grouper (♀ Epinephelus fuscoguttatus × ♂ E. lanceolatu) Fed High-Lipid Diets
Pan, S., Yan, X., Dong, X., Li, T., Suo, X., Liu, H., Tan, B., Zhang, S., Li, Z., Yang, Y., et al. (2022) · Aquaculture Nutrition · doi:10.1155/2022/6743690 · Cited by 17
The Dose-Response Effects of Consuming High Fructose Corn Syrup-Sweetened Beverages on Hepatic Lipid Content and Insulin Sensitivity in Young Adults
Sigala, D. M., Hieronimus, B., Medici, V., Lee, V., Nuñez, M. V., Bremer, A. A., Cox, C. L., Price, C. A., Benyam, Y., Abdelhafez, Y. G., et al. (2022) · Nutrients · doi:10.3390/nu14081648 · Cited by 17
Pathophysiology of type 2 diabetes mellitus
Yki‐Järvinen, H. (2011) · doi:10.1093/med/9780199235292.003.1336 · Cited by 22
Self-citation
Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content
Li, Y., van den Berg, E. H., Kurilshikov, A., Zhernakova, D. V., Gaćeša, R., Hu, S., Lopera-Maya, E. A., Zhernakova, A., Study, L. C., Aguirre‐Gamboa, R., et al. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae031 · Cited by 17
Atherogenic Dyslipidemia and Combination Pharmacotherapy in Diabetes: Recent Clinical Trials
Hamilton, S. J., & Watts, G. F. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.191 · Cited by 16
Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
Makadia, S. S., Blaha, M. J., Keenan, T. E., Ndumele, C. E., Jones, S. R., DeFilippis, A. P., Martin, S. S., Kohli, P., Conceição, R., Carvalho, J. A. M., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.001 · Cited by 17
In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats
Jonkers, R. A. M., van Loon, L. J. C., Nicolay, K., & Prompers, J. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2792-x · Cited by 17
The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats
Minakuchi, H., Wakino, S., Hosoya, K., Sueyasu, K., Hasegawa, K., Shinozuka, K., Yoshifuji, A., Futatsugi, K., Komatsu, M., Kanda, T., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv367 · Cited by 17
Etiology of Obesity, Cancer, and Diabetes
Yasmin, I., Khan, W. A., Naz, S., Iqbal, M. W., Awuchi, C. G., Egbuna, C., Hassan, S., Patrick-Iwuanyanwu, K. C., & Uche, C. Z. (2021) · Springer eBooks · doi:10.1007/978-3-030-72999-8_1 · Cited by 19
Myocardial Insulin Resistance: An Overview of Its Causes, Effects, and Potential Therapy
Toit, E. F. D., & Donner, D. G. (2012) · InTech eBooks · doi:10.5772/50619 · Cited by 18
Development of a novel method to determine very low density lipoprotein kinetics
Al-Shayji, I. A. R., Gill, J. M. R., Cooney, J., Siddiqui, S., & CASLAKE, M. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.d600044-jlr200 · Cited by 17
Self-citation
Hepatic Fat in Early Childhood Is Independently Associated With Estimated Insulin Resistance: The Healthy Start Study
Cohen, C. C., Perng, W., Sundaram, S. S., Scherzinger, A. L., Shankar, K., & Dabelea, D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab541 · Cited by 15
Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans
Borén, J., Adiels, M., Björnson, E., Matikainen, N., Söderlund, S., Rämö, J. T., Henricsson, M., Ripatti, P., Ripatti, S., Palotie, A. V., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13375 · Cited by 16
Self-citation
Tea polyphenols improve lipid metabolism in hybrid grouper (♀ Epinephelus fuscoguttatus × ♂ E. lanceolatu) fed high-lipid diets
Pan, S., Yan, X., Li, T., Suo, X., Liu, H., Tan, B., Zhang, S., Li, Z., Yang, Y., Zhang, H., et al. (2022) · Aquaculture Reports · doi:10.1016/j.aqrep.2022.101217 · Cited by 16
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease
Ren, Z., Wesselius, A., Stehouwer, C. D. A., & Brouwers, M. C. G. J. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.01.002 · Cited by 17

Authors: Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., & Borén, J.
Affiliations: University of Gothenburg (SE)
University of Helsinki (FI)
Glasgow Royal Infirmary (GB)
Sahlgrenska University Hospital (SE)
Corresponding author: Borén, J.
ORCID: Adiels, M.
Taskinen, M.-R.
Packard, C.
Häkkinen, A.
Borén, J.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2006-02-04
Volume: 49
Issue: 4
Pages: 755-765
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-005-0125-z
OpenAlex: W2051999166
Cited by: 690
References: 53
Citations by year: 2026: 15 · 2025: 26 · 2024: 29 · 2023: 21 · 2022: 35 · 2021: 29 · 2020: 40 · 2019: 31 · 2018: 27 · 2017: 27 · 2016: 37 · 2015: 41 · 2014: 41 · 2013: 45 · 2012: 38
FWCI: 26.66
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Chalmers Research (Chalmers University of Technology) (submittedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Göran Gustafssons Stiftelser
Hjärt-Lungfonden
Vetenskapsrådet
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hepatic fat content, adiponectin, apolipoprotein B, triglyceride kinetics, type 2 diabetes, insulin resistance, intra-abdominal fat, dyslipidemia
MeSH terms: Adipose Tissue, Adult, Aged, Apolipoproteins B, Diabetes Mellitus, Type 2, Fatty Liver, Humans, Lipoproteins, VLDL, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overproduction of large VLDL particles is driven by increased liver fat content in man

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks